Skip to Content

SG 307 (Nevirapine Extended-Release 400 mg)

Pill with imprint SG 307 is Yellow, Elliptical / Oval and has been identified as Nevirapine Extended-Release 400 mg. It is supplied by ScieGen Pharmaceuticals Inc..

Nevirapine is used in the treatment of reduction of perinatal transmission of hiv; hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SG 307

Nevirapine Extended-Release

Imprint
SG 307
Strength
400 mg
Color
Yellow
Size
19.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
NNRTIs
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
ScieGen Pharmaceuticals Inc.
National Drug Code (NDC)
50228-0307
Inactive Ingredients
ferric oxide yellow, lactose monohydrate, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.